### 3 Indian Growth Stocks With Up To 37% Insider Ownership ###

In This Article:

The Indian market has shown remarkable resilience, with the Utilities sector gaining 3.5% while the overall market remained flat last week and up 44% over the past year. In this thriving environment, growth companies with high insider ownership can be particularly attractive as they often signal strong confidence from those who know the business best.

Top 10 Growth Companies With High Insider Ownership In India

Name

Insider Ownership

Earnings Growth

Archean Chemical Industries (NSEI:ACI)

22.9%

33.7%

Kirloskar Pneumatic (BSE:505283)

30.3%

30.1%

Dixon Technologies (India) (NSEI:DIXON)

24.6%

31%

Jupiter Wagons (NSEI:JWL)

10.8%

27.4%

Happiest Minds Technologies (NSEI:HAPPSTMNDS)

32.5%

22.2%

Paisalo Digital (BSE:532900)

16.3%

24.8%

Apollo Hospitals Enterprise (NSEI:APOLLOHOSP)

10.4%

32.3%

Rajratan Global Wire (BSE:517522)

19.8%

35.8%

KEI Industries (BSE:517569)

18.7%

22.4%

Pricol (NSEI:PRICOLLTD)

25.5%

24%

Click here to see the full list of 92 stocks from our Fast Growing Indian Companies With High Insider Ownership screener.

We're going to check out a few of the best picks from our screener tool.

Dixon Technologies (India)

Simply Wall St Growth Rating: ★★★★★★

Overview: Dixon Technologies (India) Limited provides electronic manufacturing services both in India and internationally, with a market cap of ?837.45 billion.

Operations: The company's revenue segments include Home Appliances (?12.51 billion), Lighting Products (?7.92 billion), Mobile & EMS Division (?143.16 billion), and Consumer Electronics & Appliances (?41.21 billion).

Insider Ownership: 24.6%

Dixon Technologies (India) is forecast to achieve substantial revenue growth at 24% annually, significantly outpacing the Indian market's 10.2%. Earnings are expected to grow at 31% per year, also surpassing market expectations of 17.3%. The company reported impressive financial results for Q1 2024 with revenue doubling to ?65.88 billion and net income rising to ?1.34 billion compared to the previous year, reflecting robust operational performance and growth potential.

NSEI:DIXON Earnings and Revenue Growth as at Sep 2024
NSEI:DIXON Earnings and Revenue Growth as at Sep 2024

Indoco Remedies

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Indoco Remedies Limited manufactures, markets, and sells formulations and active pharmaceutical ingredients in India and internationally, with a market cap of ?34.76 billion.

Operations: The company generates revenue of ?18.22 billion from its pharmaceuticals segment.